FDA Recalls 12 Million Cartons of Eye Drops Over Sterility Concerns
The FDA has initiated a recall of nearly 12 million cartons of eye drops nationwide due to concerns about sterility.
Tampa St. Petersburg, FL, July 29, 2026 —
The U.S. Food and Drug Administration (FDA) has announced a nationwide recall impacting approximately 12 million cartons of eye drops. The action is being taken due to significant concerns regarding the sterility of the products.
The specific brands and manufacturers involved in the recall were not detailed in the initial announcement. The FDA has not yet provided information on the exact nature of the sterility concerns or the specific products affected beyond the large quantity of cartons recalled.
Sterility is a critical factor for ophthalmic products, as any contamination can lead to serious eye infections, potentially causing vision impairment or blindness. The FDA’s involvement indicates a proactive measure to prevent potential harm to consumers.
Details regarding the timeline of the recall, including when the issues were identified and the exact date the recall was initiated, have not been publicly released. Consumers are advised to check for further communications from the FDA and the affected manufacturers for specific product identification and instructions.
The number of affected cartons, nearing 12 million, suggests a widespread issue within the supply chain or manufacturing process. The FDA typically provides detailed information on its website regarding ongoing recalls, including reasons, affected products, and guidance for consumers and healthcare providers.
Further updates are expected as the FDA continues its investigation and communicates with the companies involved in the production and distribution of these eye drops.
Story summarized from the original created by Nathaniel Rodriguez on www.wfla.com, see more information here.
